Behavioural Neurology
Volume 2017 (2017), Article ID 4160259, 9 pages
https://doi.org/10.1155/2017/4160259

Review Article

Depression after Stroke in Sub-Saharan Africa: A Systematic Review and Meta-Analysis

Akin Ojagbemi,¹ Onoja Akpa,¹ Fisayo Elugbadebo,² Mayowa Owolabi,¹ and Bruce Ovbiagele³

¹College of Medicine, University of Ibadan, Ibadan, Nigeria
²University College Hospital, Ibadan, Nigeria
³Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

Correspondence should be addressed to Akin Ojagbemi; drakinjagbemi@yahoo.com

Received 7 March 2017; Revised 15 May 2017; Accepted 31 May 2017; Published 27 July 2017

Academic Editor: Giuseppe Bellelli

Copyright © 2017 Akin Ojagbemi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Objective. We aimed to conduct a systematic review and meta-analysis of prevalence and characteristics of poststroke depression (PSD) in sub-Saharan Africa (SSA). Methods. We searched Medline, PsycINFO, and African Journals OnLine using keywords for stroke and depression and the .mp. operator for all 54 SSA countries/regions. Further information was retrieved through a manual search of references from relevant published and unpublished articles. We included only peer-reviewed original studies with epidemiological or experimental designs, conducted random-effect meta-analysis, and identified the most commonly associated factors by weight (inverse of variance method). Results. Seventeen studies, comprising 1483 stroke survivors, met the criteria for syntheses. The pooled frequency of clinically diagnosed PSD was 31% (95% CI = 26%–36%), versus 13.9% in healthy control pairs. Prevalence did not vary much across healthcare settings but was affected by methods of depression ascertainment. PSD was significantly associated with low education, cognitive impairment, physical disability, poor quality of life, and divorced marital status. Conclusion. Almost 1 in 3 individuals with stroke in SSA has clinical depression. Despite limitations around quality of identified studies, results of the present systematic review overlap with findings in the global literature and highlight useful targets for the design and trial of tailored intervention for PSD in SSA.

1. Introduction

There is an escalating burden of stroke in sub-Saharan Africa (SSA), which is now among the leading causes of disease and disability in the region [1]. A key complication of stroke is depression, which while being associated with tremendous poststroke morbidity is frequently under-recognized and undertreated, especially in SSA, where resources are relatively limited and the issues of mental health are underappreciated.

A recently published scientific statement on poststroke depression (PSD) by the American Heart Association/American Stroke Association (AHA/ASA) [2] highlighted the current state of evidence regarding scientific knowledge and clinical practice of PSD. However, there was only one study from SSA [3] out of a combined total of 236 citations in the five systematic reviews [4–8] in the AHA/ASA statement.

The limited data on PSD in SSA in the AHA/ASA scientific statement was likely due to the publication of African studies in typically less visible and less accessible media, such as databases of African literature. Yet, extrapolating results derived from a global pool of studies to SSA may mask the true state of burden of depression in stroke survivors living in the subregion.

The objective of this study was to conduct a systematic review and meta-analysis of PSD studies among patients in SSA to arrive at a pooled estimate of prevalence and to identify the qualitative and quantitative relationships of key clinical characteristics with occurrence of PSD.

2. Methods

This review followed conventional recommendations for the methodology and reporting of systematic reviews [9, 10].

2.1. Search Strategy

The search strategy aimed to find both published and unpublished studies. An initial search of the African Journal OnLine (12 February 2017; repeated 14 May 2017), Medline (Ovid SP 1946—15 February 2017; repeated 14 May 2017), and PsycINFO (Ovid SP 1806—16 February 2017) databases was conducted using the following keywords with the “explode” operator: stroke OR poststroke OR “cerebrovascular accident” OR “Cerebrovascular disorder” OR “stroke survivors” AND depression OR “major depression” OR “major depressive disorder” OR “depressive symptoms” OR “poststroke emotional disorders” OR “emotional response” AND epidemiology OR frequency OR prevalence OR incidence OR factors OR “risk factors” OR “associated factors” OR “precipitating factors” OR “predisposing factors” OR outcome OR mortality. We next used the .mp. operator to search each of the 54 SSA countries or regions by name.

A second stage consisting of hand searching of the reference list of relevant articles retrieved from the databases was also implemented.

Limits on language and publication dates were not imposed in conducting the searches.

2.2. Inclusion Criteria

2.2.1. Types of Participants

We included studies involving stroke survivors regardless of the method of stroke diagnoses in both the qualitative and quantitative components of the review.

2.2.2. Types of Phenomena of Interest

We included studies investigating epidemiological phenomena such as frequencies, prevalence, incidence, risk or associated factors, and outcome in both the qualitative and quantitative components of the review.

2.2.3. Types of Studies Included

We have the following:

(i)Studies where participants were recruited from their homes (herein and after referred to as community studies), hospital, rehabilitation settings, nursing homes, or other such institutions.(ii)Studies with epidemiological or experimental study designs. This included descriptive and analytical cross-sectional studies, prospective and retrospective cohort studies, case control studies, randomized controlled trials, nonrandomized controlled trials, quasi-experimental studies, and before and after studies.

2.3. Exclusion Criteria

We have the following:

(i)Nonhuman literature(ii)Review papers(iii)Case series and individual case reports(iv)Studies focusing solely on qualitative data(v)Other textual materials such as expert opinion, discussion papers, and position papers.

2.4. Study Assessments and Data Extraction

Study assessment for inclusion and exclusion criteria as well as subsequent data extraction was conducted by two independent assessors based on the descriptions in the original article. It was agreed a priori that in cases of disagreement, a consensus will be reached based on the decision of an experienced colleague.

2.4.1. Ascertainment of Risk of Bias in Studies Exploring Associations

A standard framework for assessing biases in studies investigating associations between variables [9, 11] was used for judgments about the risk of bias in studies describing associations. All 5 steps in the modified Graphical Appraisal Tool for Epidemiologic (GATE) studies [9, 11] were used for the determination of the risk of bias. We determined external validity by assessing key characteristics of the eligible sample in the relevant studies and made judgments about the level of representativeness of the source population. We made judgment about internal validity by assessing the method of identification of stroke survivors, outcome measurements, and analytical strategies. These steps were undertaken to ensure that the associations identified by the respective studies are valid and are not due to unidentified factors that may be related to both exposure and outcome.

Risk of bias was classified as low, unclear/unknown, and high [9]. Points were allocated to each component of the study as follows: 2 points when the risk of bias was low, 1 point when this was unclear/unknown, and no points when the risk of bias was clearly high. Judgment about overall risk of bias in the selected studies was made by averaging risk of bias for a particular study and calculated by summing up the total points accrued by that study and dividing the result by the total number of components assessed. Finally, we classified the overall risk of bias for a particular study as high (when the average risk of bias scores for that study is less than 1), moderate (when this is between 1 and 1.5), and low (when the score is greater than 1.5).

2.5. Statistical Methods

Meta-analysis was conducted using prevalence estimates of PSD reported in the original articles meeting the criteria for quantitative synthesis. We centered the display of prevalence estimate on a point of zero for the purpose of illustration.

As heterogeneity was expected due to differences in the type of depression assessments (diagnostic or rating scales), as well as setting of studies, a random-effect meta-analysis model was chosen. To reduce the extent of methodological heterogeneity, we combined studies with similar diagnostic procedures in the same meta-analysis model. To determine the extent of statistical heterogeneity, we estimated the percentage of total variation in estimates reported across studies that is due to heterogeneity, rather than chance. This was computed using the I ² test. Values of I ² > 50% are often regarded as evidence of statistical heterogeneity [12]. In considering clinical heterogeneity, additional subgroup meta-analyses based on the setting of the studies (i.e., medical inpatients, outpatients, or physical rehabilitation) were conducted.

For the objective of investigating the most important factors associated with PSD by rank, we used the log of odds ratios (OR) and the corresponding standard errors (SE) of the associations. The inverse of variance method was used for weighing in all quantitative estimations.

All quantitative analyses were conducted using the “metan” add-on in Stata version 12.0 [13] and Cochrane review manager (Revman) version 5.3 software [14].

3. Results

3.1. Search Results

The combined database, unpublished literature, and hand searches identified a total of 74 records. After removing duplicates in either database (), the titles and abstract of 18 articles were screened. The full texts of all 18 articles were retrieved. After reading through the texts, one article from South Africa [15] was excluded as depression was not directly measured. The authors used a visual analogue scale to measure broadly defined emotional reactions in stroke survivors with aphasia.

Studies included were conducted between October 1998 and January 2017. Other details of included and excluded studies are shown on the flow chart in Figure 1.

Figure 1: Flow chart showing details of included and excluded studies.

3.2. Qualitative Appraisal of Identified Studies

3.2.1. Geographical Location of Studies

All included studies came from primarily two regions in sub-Saharan Africa: West Africa and East Africa. However, about 65% of identified studies were from one country, Nigeria.

3.2.2. Types of Study Design and Methods

Ten of the 17 included studies were of cross-sectional designs, two studies included stroke survivors and healthy control pairs [16, 17], and the remaining 5 were prospective observational studies of between 2- and 12-month duration [18–22].

While many studies were set up to explore prevalence () (Table 1) and associated factors (), only very few investigated relationship of depression with stroke outcomes () [17, 18, 21, 23, 24]. None of the studies investigated incidence of PSD or the risk factors for new onset of the disorder.

Table 1: Prevalence of poststroke depression in sub-Saharan Africa.

Reference
Country/location
Type of study
Definition of depression
Sample size
Female (%)
Age mean (SD)
Time since stroke
Prevalence (%)

Medical inpatient clinics

Napon et al., 2010
Burkina Faso
Observational
(2 months)
Montgomery and Asberg Depression Rating Scale (MADRS).
167
52.3
56.9 (29–84)a
2 weeks
38.9

Gbiri et al., 2010
Nigeria
Observational
(6 months)
Center for Epidemiological Study of Depression Scale (CES-D)
65
49.2
58.1 (15.7)
0–6 months
40.4

Medical outpatient clinics

Oladiji et al., 2009
Nigeria
Cross-sectional
Depression, Anxiety and Stress Scale
51
39.2
52.5 (5.9)
5–18 months
25.2

Fatoye et al., 2009
Nigeria
Cross-sectional
Beck’s Depression Inventory
118
42.4
59.6 (10.5)
1–24 months
38.8

Ajiboye et al., 2013
Nigeria
Cross-sectional
Schedules for Clinical Assessment in Neuropsychiatry (SCAN)/ICD-10
83
55.4
60.6 (13.2)
3–84 months
19.2

Gyagenda et al., 2015
Uganda
Cross-sectional
Patient Health Questionnaire-9
73
58.9
57.3 (20–99)a
NR
31.5

Sarfo et al., 2017
Ghana
Cross-sectional
Center for Epidemiological Study of Depression Scale (CES-D)/Geriatric Depression Scale (GDS)
200
47.5
62 (52–72)a
12–48 months
36.5

Physical rehabilitation settings

Olayinka, 1998
Nigeria
Cross-sectional
Psychiatric Assessment Schedule (DSM III-R)
86
40.7
55.4 (9.1)
0–72 months
32.6

Mpembi Nkosi et al., 2013
Democratic Republic of Congo
Observational (1 year)
Patient Health Questionnaire (PHQ9)
30
30.0
55.9 (12.7)
NR
26.7

Mpembi Nkosi et al., 2014
Democratic Republic of Congo
Cross-sectional
Patient Health Questionnaire (PHQ9)
56
37.5
54.5 (12.6)
60.7% > 1 year
21.4

Ojagbemi et al., 2014
Nigeria
Case-control
Schedules for Clinical Assessment in Neuropsychiatry
(SCAN)/DSM-IV
130
53.9
59.5 (11.1)
3–24 months
41.5

NR = not reported; arange.

Four [19, 25–27] of the 9 studies investigating cross-sectional associations with PSD cited factors without systematically investigating their association with the disorder (i.e., they did not use appropriate analytical techniques in establishing associations). The remaining five studies described the source population and sampling frame. They also provided estimates of OR or sufficient data to allow for such estimation. However, two [28, 29] of these five studies had limitations of sample size. The combined risk of bias, as assessed using the modified GATE criteria, in the five studies reporting factors that are systematically associated with poststroke depression was moderate.

3.2.3. Assessment for Depression

All included studies used valid methods for the ascertainment of depression. While most relied on a variety of rating scales, clinical interview and formal diagnostic criteria were used in five studies [16, 24, 26, 28, 30]. Only one of these studies [30] used the criteria in the 10th revision of the International Classification of Diseases (ICD-10) [31]. The other studies using clinical diagnostic criteria relied on the Diagnostic and Statistical Manual of Mental Disorders [32].

3.2.4. Healthcare Settings of Studies

Nearly one-half (47.1%) of the studies were conducted in physical rehabilitation settings. Notably, only one study [17] included participants recruited from their homes, rather than in hospital or physical rehabilitation settings. The remaining eight studies were conducted among medical inpatients [20–22] or outpatients [3, 25, 27, 30].

3.2.5. Participant Characteristics

Most of the identified studies did not specify types or severity of stroke, nor were detailed exclusion criteria reported. Two studies included participants who were within a 6-month poststroke period [20, 22]. The other studies were heterogeneous in terms of poststroke periods investigated.

3.3. Quantitative Syntheses

3.3.1. Prevalence of PSD

Figures 2 and 3 are forest plots showing the prevalence of depression in studies meeting the criteria for quantitative syntheses. The 95% confidence intervals of each estimate together with their quantitative summary are also presented. Greater weights are given to studies with narrower confidence intervals. The pooled frequency of clinically diagnosed PSD was 31% (95% CI = 26%–36%). There was an indication of statistical heterogeneity in this estimate (I ² = 85.1%, ). This was due to one study [30] reporting an unusually low prevalence of PSD in a Nigerian medical outpatient clinic (Figure 2). That study was the only study in the present review using the ICD-10 criteria. It is unclear whether, or how, this ascertainment procedure might have affected the results of that study [30]. In analyses conducted to minimize heterogeneity (Figures 3 and 4), there were no remarkable differences in pooled rates reported across healthcare settings. The highest pooled frequency (39%) was found among medical inpatients. However, the prevalence of PSD in the studies appears to be dependent on ascertainment procedure. For example, using rating scales in rehabilitation settings, a pooled frequency of 23% was estimated, whereas formal diagnostic assessments in the same healthcare setting produced a pooled frequency of 38% (Figure 4). The frequency of depression in healthy control pairs was found to be 13.9% in the only study [16] including such participants.

Figure 2: Forest plot showing the pooled prevalence of clinically diagnosed poststroke depression in sub-Saharan Africa.

Figure 3: Forest plots showing the pooled prevalence of poststroke depression (using rating scales) in medical inpatient/outpatient clinics.

Figure 4: Forest plots showing the pooled prevalence of poststroke depression in the rehabilitation setting.

3.3.2. Cross-Sectional Associations with PSD

The factors with the most precise systematic association with PSD, by weight and in decreasing order, were low levels of education, cognitive impairment, physical disability, and divorced marital status (Table 2). However, the most frequently cited factors in studies were female gender and physical disability. Though highly cited, the association of female gender with PSD was weakened by inflated SEs in studies reporting this association.

Table 2: The most common factors associated with poststroke depression in sub-Saharan Africa.

Independently associated factors
Estimated standard errors of association
Weight (%)

    Low educationa
0.04
38.8

    Cognitive impairmentb
0.08
37.6

    Physical disabilityc
0.34
21.0

    Divorced marital statusa
1.41
2.4

    Apathyb
13.3
<0.1

    Female genderc
20.7
<0.1

    Poor self-reported health statusa
76.7
<0.1

Cited, not systematically associated
Reference
Sample size

    Personal history of mental illness
Olayinka, 1998
86

    Family history of mental illness
Olayinka, 1998
86

    Poor social support
Olayinka, 1998
86

    Right-side laterality
Oladiji et al., 2009
51

    Older age
Mpembi Nkosi et al., 2014
30

    Sleep disturbance
Mpembi Nkosi et al., 2014
30

aOne study; btwo studies; cfour studies.

3.3.3. Association of Depression and Stroke Outcomes

Poor quality of life, which was the most frequently cited outcome of stroke linked to depression, was systematically investigated in only one multivariate analysis (Table 3). Although poor sexual health and functional dependency after stroke were also linked to depression, only functional dependency was investigated in a multivariate analysis.

Table 3: Outcome of poststroke depression in sub-Saharan Africa.

Reference
Country/location
Type of study
Definition of depression
Outcome
Effect estimate
Effect (yes/no)

Howitt et al., 2011
Tanzania
Cross-sectional
Hospital Anxiety Depression Scale
Poor quality of life
−0.4a
Yes

Gbiri and Akinpelu, 2012
Nigeria
Observational (12 months)
Center for Epidemiological Study of Depression Scale (CES-D)
Poor quality of life
−0.8b
Yes

Akinpelu et al., 2013
Nigeria
Cross-sectional
Beck’s Depression Inventory
Poor sexual satisfaction; poor ejaculation
454.5c
Yes

236.5c
Yes

Ojagbemi and Owolabi, 2013
Nigeria
Cross- sectional
Schedules for Clinical Assessment in Neuropsychiatry (SCAN)/DSM IV
Functional dependency
3.1b
Yes

Hamza et al., 2014
Nigeria
Observational (12 months)
Beck’s Depression Inventory
Poor quality of life
−0.2d
Yes

aPearson correlation coefficient; badjusted odds ratio in logistic regression; cMann–Whitney U test; dbeta for multiple linear regression.

4. Discussion

In conducting a comprehensive pooled review of the prevalence and characteristics of PSD in SSA, key observations were made. The pooled frequency of clinically diagnosed PSD in SSA is 31%. Prevalence did not vary much across healthcare settings but appeared to be affected by methods of depression ascertainment (diagnostic assessments or rating scales). PSD was significantly linked to cognitive and functional deficits, as well as low levels of education and divorced marital status. Depression in this population was also linked to poor quality of life and functional dependency after stroke.

The observations in the present review are made within limitations of the quality of available data. There were many small studies. These studies were also very different in the types of healthcare settings of stroke survivors. For example, stroke survivors in medical inpatient settings, physiotherapy, and community can be expected to have varying degrees of morbidity. Additional differences in the study were the use of a variety of methodologies in the ascertainment of both stroke and depression in the identified studies, thus limiting a meaningful inclusion of many studies in our quantitative syntheses without compromising heterogeneity. Given these limitations, well-designed studies, especially including prospective observation, adequate sample sizes, well-defined cohorts of stroke survivors, are still required to better situate the evidence-practice gap of PSD in SSA.

Despite the above limitations, the pooled frequency of PSD reported in the present review overlaps with findings from the two largest systematic reviews estimating the global prevalence of PSD. In the review by Hackett et al. [5] including 51 studies (reported in 96 publications) globally before June 2004, the pooled frequency of PSD was 33% (95% CI = 29%–36%). In the subsequent systematic review by Ayerbe et al. [6] including 43 cohorts published before August 2011, a pooled frequency of 29% (95% CI = 25%–32%) was reported. We note that these large systematic reviews of the global literature on the PSD did not include about 95% of the studies identified in the present investigation.

We were unable to provide robust data depicting the natural history of PSD by estimating incidence and prevalence across different poststroke periods because most of the studies identified in the present systematic review were cross-sectional in design.

Even though the global literature suggests that both biological and psychological factors are pathophysiologically linked to PSD [2], our data suggests that, in SSA, the disorder has so far been associated with reduced social and economic potential to cope with (physical and cognitive) disability. We note that as in many low- and middle-income countries, levels of formal education and marital status are important proxies of social and economic positions in SSA [33]. In this regard, having little formal education and no spousal support may be associated with social and economic disadvantages.

Biological factors that have been associated with PSD in the global literature include problems with the mechanisms of cerebral blood flow [34], neurotransmitters, and inflammatory cytokines [35], as well as gene polymorphism [36]. In the only study identified in the present review where the association between depression and stroke types, lesion, and their brain locations was investigated [28], these biological factors showed no cross-sectional association with depression (lesion characteristic OR = 0.4, 95% CI = 0.0–6.2). Similar to the global evidence [2], PSD in SSA has also been systematically linked with poor quality of life and functional dependency after stroke.

In reviewing the existing evidence, a number of gaps in the SSA literature on PSD have emerged that are of potential relevance for the design of such future studies.

4.1. The Incidence and Natural History of PSD in SSA

Globally, about one-third of stroke survivors will experience depression at some point in the poststroke period [4]. The evidence suggests that rates of new onset depression do not vary much in the first year poststroke. The five observational studies identified in the current systematic review missed an opportunity to estimate the incidence of PSD in their sample. Given the unique social, economic, and cultural circumstances in SSA, it is yet unclear whether rates of new onset depression after stroke may vary one way or another compared with reported rates from other parts of the world.

4.2. Biological Factors Contributing to the Pathophysiology of PSD in SSA

Studies from other parts of the world suggest that PSD is not merely a psychological response to disability [35, 36] as several biological factors have been implicated in the pathophysiology of the disorder. As earlier stated, we identified one small study investigating whether stroke lesion characteristics are associated with PSD [28]. That study cross-sectionally analyzed the computerized tomography images of 30 patients and found no relationship between stroke lesions and depression. As such, the relevant biological factors for PSD in survivors living in SSA remain to be investigated.

4.3. Effective Interventions for PSD in SSA

The global literature suggests that a wide range of effective pharmacological and nonpharmacological interventions have been designed and tested for the prevention and treatment of PSD in other parts of the world [2]. Studies aiming to design and test tailored interventions for the prevention or treatment of PSD are yet to be conducted in SSA. The finding in the present systematic review, suggesting that measures of reduced social and economic potential to cope with (physical and cognitive) disability may be important in the pathophysiology of PSD, provides important leads for the design and testing of culturally relevant and tailored intervention for the disorder in the subregion.

4.4. Strength and Limitations

The search strategy was designed to be meaningfully sensitive. In this regard, the searches have focused on some of the largest repository of biomedical literature with additional strategy to cover African and unpublished literature, including manual searches of the references of the appraised articles. Nevertheless, the interpretation of our results is limited by the small number of good-quality studies of association of several factors with PSD.

5. Conclusion

The pooled frequency of clinically diagnosed PSD in SSA is 31%. It is linked to functional dependency and poor quality of life after stroke. These findings overlap with reports in the global literature. However, PSD in SSA has so far been cross-sectionally associated with indices of reduced social and economic advantages in the face of cognitive and functional deficits. While there are subsisting evidence gaps precluding meaningful estimate of the full extent of the burden, the findings in the present systematic review provide useful targets for the design and trial of tailored intervention for the prevention and treatment of PSD in the subregion.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this article.

Acknowledgments

The first author acknowledges the support from the Department of Old Age Psychiatry, Institute of Psychiatry Psychology and Neurosciences, King’s College London.

References

A. Moran, M. Forouzanfar, U. Sampson, S. Chugh, V. Feigin, and G. Mensah, “The epidemiology of cardiovascular diseases in sub-Saharan Africa: the Global Burden of Diseases, Injuries and Risk Factors 2010 Study,” Progress in Cardiovascular Diseases, vol. 56, no. 3, pp. 234–239, 2013.

A. Towfighi, B. Ovbiagele, N. El Husseini et al., “Poststroke depression: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association,” Stroke, vol. 48, no. 2, pp. e30–e43, 2017.

F. O. Fatoye, S. K. Mosaku, M. A. Komolafe et al., “Depressive symptoms and associated factors following cerebrovascular accident among Nigerians,” Journal of Mental Health, vol. 18, no. 3, pp. 224–232, 2009.

M. L. Hackett and K. Pickles, “Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies,” International Journal of Stroke, vol. 9, no. 8, pp. 1017–1025, 2014.

M. L. Hackett, C. Yapa, V. Parag, and C. S. Anderson, “Frequency of depression after stroke: a systematic review of observational studies,” Stroke, vol. 36, no. 6, pp. 1330–1340, 2005.

L. Ayerbe, S. Ayis, C. D. Wolfe, and A. G. Rudd, “Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis,” The British Journal of Psychiatry, vol. 202, no. 1, pp. 14–21, 2013.

L. Ayerbe, S. A. Ayis, S. Crichton, C. D. Wolfe, and A. G. Rudd, “Natural history, predictors and associated outcomes of anxiety up to 10 years after stroke: the South London Stroke Register,” Age and Ageing, vol. 43, no. 4, pp. 542–547, 2014.

A. De Ryck, R. Brouns, M. Geurden, M. Elseviers, P. P. De Deyn, and S. Engelborghs, “Risk factors for poststroke depression: identification of inconsistencies based on a systematic review,” Journal of Geriatric Psychiatry and Neurology, vol. 27, no. 3, pp. 147–158, 2014.

National Institute for health and Care Excellence, The Guidelines Manual: Process and Method Guide, National Institute for health and Care Excellence, London, 2012.

D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, and PRISMA Group, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” Open Med, vol. 3, no. 3, pp. e123–e130, 2009.

R. Jackson, S. Ameratunga, J. Broad et al., “The GATE frame: critical appraisal with pictures,” Evidence-Based Medicine, vol. 11, no. 2, pp. 35–38, 2006.

A. G. Habib, A. M. Yakasai, L. F. Owolabi et al., “Neurocognitive impairment in HIV-1-infected adults in sub-Saharan Africa: a systematic review and meta-analysis,” International Journal of Infectious Diseases, vol. 17, no. 10, pp. e820–e831, 2013.

StataCorp, Stata Statistical Software: Release 13, StataCorp LP, College Station, TX, 2013.

The Cochrane Collaboration, Review Manager (RevMan) [Computer Program], The Cochrane Collaboration: The Nordic Cochrane Centre, Copenhagen, 2014.

T. Smollan and C. Penn, “The measurement of emotional reaction and depression in a South African stroke population,” Disability and Rehabilitation, vol. 19, no. 2, pp. 56–63, 1997.

A. Ojagbemi, R. Akinyemi, and O. Baiyewu, “Cognitive dysfunction and functional limitations are associated with major depression in stroke survivors attending rehabilitation in Nigeria,” NeuroRehabilitation, vol. 34, no. 3, pp. 455–461, 2014.

S. C. Howitt, M. P. Jones, A. Jusabani et al., “A cross-sectional study of quality of life in incident stroke survivors in rural northern Tanzania,” Journal of Neurology, vol. 258, no. 8, pp. 1422–1430, 2011.

A. M. Hamza, N. Al-Sadat, S. Y. Loh, and N. K. Jahan, “Predictors of poststroke health-related quality of life in Nigerian stroke survivors: a 1-year follow-up study,” BioMed Research International, vol. 2014, Article ID 350281, 7 pages, 2014.

M. Mpembi Nkosi, S. Mampunza Ma Miezi, V. Massamba Kubuta et al., “Clinical course of post-stroke depression in Kinshasa,” Revue Neurologique (Paris), vol. 170, no. 10, pp. 614–620, 2014.

C. A. Gbiri, A. O. Akinpelu, and A. C. Odole, “Prevalence, pattern and impact of depression on quality of life of stroke survivors,” International Journal of Psychiatry in Clinical Practice, vol. 14, no. 3, pp. 198–203, 2010.

C. A. Gbiri and A. O. Akinpelu, “Quality of life of Nigerian stroke survivors during first 12 months post-stroke,” Hong Kong Physiotherapy Journal, vol. 30, no. 18, article e24, 2012.

C. Napon, A. Kabore, and J. Kabore, “Post stroke depression in Burkina Faso,” The Pan African Medical Journal, vol. 13, p. 3, 2012.

A. O. Akinpelu, A. A. Osose, A. C. Odole, and N. A. Odunaiya, “Sexual dysfunction in Nigerian stroke survivors,” African Health Sciences, vol. 13, no. 3, pp. 639–645, 2013.

A. Ojagbemi and M. Owolabi, “Predictors of functional dependency after stroke in Nigeria,” Journal of Stroke and Cerebrovascular Diseases, vol. 22, no. 8, pp. e381–e387, 2013.

J. O. Oladiji, S. R. Akinbo, O. F. Aina, and C. B. Aiyejusunle, “Risk factors of post-stroke depression among stroke survivors in Lagos, Nigeria,” African Journal of Psychiatry (Johannesbg), vol. 12, no. 1, pp. 47–51, 2009.

M. O. Olayinka, “Post stroke depression: prevalence and associated factors,” in Psychiatry, West-African College of Physicians Lagos, Nigeria, 1998.

J. O. Gyagenda, E. Ddumba, R. Odokonyero et al., “Post-stroke depression among stroke survivors attending two hospitals in Kampala Uganda,” African Health Sciences, vol. 15, no. 4, pp. 1220–1231, 2015.

A. Ojagbemi, M. Owolabi, M. Atalabi, and O. Baiyewu, “Stroke lesions and post-stroke depression among survivors in Ibadan, Nigeria,” African Journal of Medicine and Medical Sciences, vol. 42, no. 3, pp. 245–251, 2013.

M. N. Mpembi, S. M. Miezi, T. M. Nzuzi et al., “Clinical profile of post-cerebrovascular depression: descriptive cross-sectional study in the rehabilitation center for people with disabilities of Kinshasa (DR Congo),” The Pan African Medical Journal, vol. 17, p. 109, 2014.

P. O. Ajiboye, O. A. Abiodun, M. F. Tunde-Ayinmode, O. I. Buhari, E. O. Sanya, and K. W. Wahab, “Psychiatric morbidity in stroke patients attending a neurology clinic in Nigeria,” African Health Sciences, vol. 13, no. 3, pp. 624–631, 2013.

World Health Organisation, International Classification of Diseases: 10th Revision (ICD 10), World Health Organisation, Geneva, 10 edition, 1992.

American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders: 4th Edition (DSM IV) Text Revision (Ed), American Psychiatric Association, Washington DC, 4 edition, 1994.

A. Ojagbemi, T. Bello, Z. Luo, and O. Gureje, “Living conditions, low socioeconomic position, and mortality in the Ibadan study of aging,” The Journals of Gerontology Series B, Psychological Sciences and Social Sciences, 2016.

S. Yamaguchi, S. Kobayashi, H. Koide, and T. Tsunematsu, “Longitudinal study of regional cerebral blood flow changes in depression after stroke,” Stroke, vol. 23, no. 12, pp. 1716–1722, 1992.

G. Spalletta, P. Bossù, A. Ciaramella, P. Bria, C. Caltagirone, and R. G. Robinson, “The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines,” Molecular Psychiatry, vol. 11, no. 11, pp. 984–991, 2006.

I. Loubinoux, G. Kronenberg, M. Endres et al., “Post-stroke depression: mechanisms, translation and therapy,” Journal of Cellular and Molecular Medicine, vol. 16, no. 9, pp. 1961–1969, 2012.